【摘要】 目的 评价合并快速型心律失常的危重患者静脉应用胺碘酮的疗效及安全性。方法 选择合并快速型心律失常的危重患者72例，其中61例伴有不同程度的心力衰竭。患者均静脉应用胺碘酮，并给予胺碘酮口服治疗。将心律失常转复为窦性心律或心率明显减慢评价为显效；心律失常未纠正但心率减慢评为有效；心律失常未纠正且心率未减慢评为无效。密切监测用药前后血压、心率、药物不良反应及心力衰竭情况。结果 72例患者中显效率63.89%，有效率30.56%，无效率5.55%。大部分患者心力衰竭有不同程度改善，无心力衰竭加重者，未发生严重药物不良反应。结论 合并快速型心律失常的危重患者，特别是合并心力衰竭的患者，静脉应用胺碘酮是安全的，疗效是确切的。

    【关键词】 胺碘酮；快速型心律失常;静脉应用;危重病

    Study on intravenous amiodarone in critically ill patients with tachycardiac arrhythmia

    LIU Mei-miao，YU Xue-tao,LIN Qiu-ping.

    Department of Emergency , The First Affiliated Hospital of Shantou University Medical College,Shantou 515041,China

    【Abstract】 Objective To evaluate the efficacy and safety of intravenous amiodarone for the critically ill patients with tachycardiac arrhythmia.Methods 72 critically illness with tachycardiac arrhythmia received intravenous amiodarone and oral amiodarone were included in this study. 61 patients were in different degree of heart failure. Blood pressure ,heart rate and degree of heart failure were compared before and after intravenous amiodarone. Effects and side effects of intravenous am1iodarone were analyzed.Results Clearly effect ......